scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Christopher Pittenger | Q56905462 |
P2093 | author name string | Matthew State | |
Michael Bloch | |||
P2860 | cites work | Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism | Q24299042 |
Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene | Q24305575 | ||
Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders | Q24305646 | ||
A functional genetic link between distinct developmental language disorders | Q24312638 | ||
X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family | Q24534259 | ||
Contemporary assessment and pharmacotherapy of Tourette syndrome | Q24607941 | ||
Strong association of de novo copy number mutations with autism | Q24633543 | ||
Microduplications of 16p11.2 are associated with schizophrenia | Q24634151 | ||
A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism | Q24643479 | ||
Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes | Q24655755 | ||
Tourette Syndrome and learning disabilities | Q24814345 | ||
Treatment of ADHD in children with tics: a randomized controlled trial | Q28203774 | ||
Tourette's syndrome: from behaviour to biology | Q28235908 | ||
Association between microdeletion and microduplication at 16p11.2 and autism | Q28264205 | ||
Familial deletion within NLGN4 associated with autism and Tourette syndrome | Q28266485 | ||
Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2 | Q29616085 | ||
Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data | Q30935519 | ||
Neuroimaging of Tourette syndrome | Q33257487 | ||
Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome | Q33758561 | ||
Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum. | Q33835219 | ||
Tourette syndrome is associated with recurrent exonic copy number variants | Q33878013 | ||
Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome | Q33947856 | ||
L-histidine decarboxylase and Tourette's syndrome | Q33951417 | ||
CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder | Q34206301 | ||
Antipsychotic-induced weight gain: a review of the literature | Q34247423 | ||
Coincident but distinct messages of midbrain dopamine and striatal tonically active neurons | Q34331030 | ||
Behavior therapy for children with Tourette disorder: a randomized controlled trial | Q34358503 | ||
Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders | Q34505703 | ||
Association between maternal smoking and increased symptom severity in Tourette's syndrome | Q34533147 | ||
Histamine in the nervous system | Q34795903 | ||
Prevalence of diagnosed Tourette syndrome in persons aged 6-17 years - United States, 2007. | Q34985054 | ||
Genetic analysis of Tourette syndrome suggesting major gene effect | Q35201718 | ||
Intermediate inheritance of Tourette syndrome, assuming assortative mating | Q35643672 | ||
Family study and segregation analysis of Tourette syndrome: evidence for a mixed model of inheritance | Q35882325 | ||
Behavioral and affective disorders in Tourette syndrome | Q36420951 | ||
Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome | Q36536128 | ||
Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome | Q36632056 | ||
Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders | Q37618812 | ||
The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: a cross-cultural perspective | Q37632893 | ||
The Genetics of Child Psychiatric Disorders: Focus on Autism and Tourette Syndrome | Q37801080 | ||
Fgfr1 is required for cortical regeneration and repair after perinatal hypoxia | Q38357013 | ||
Language-based cognitive functioning in parents of offspring with ADHD comorbid for Tourette syndrome or learning disabilities | Q38444204 | ||
A functional neuroanatomy of tics in Tourette syndrome | Q39171985 | ||
Autosomal Dominant Gene Transmission in a Large Kindred with Gilles de la Tourette Syndrome | Q41125835 | ||
The inheritance of Gilles de la Tourette's syndrome and associated behaviors. Evidence for autosomal dominant transmission | Q41444981 | ||
Genetic hypotheses for Tourette syndrome. | Q41611687 | ||
A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome | Q43281863 | ||
Developmental psychopathology of children and adolescents with Tourette syndrome--impact of ADHD. | Q43456142 | ||
Psychiatric outcomes in low-birth-weight children at age 6 years: relation to neonatal cranial ultrasound abnormalities | Q44117002 | ||
Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice | Q44208834 | ||
Tic reduction with pergolide in a randomized controlled trial in children | Q44324832 | ||
Basal Ganglia volumes in patients with Gilles de la Tourette syndrome | Q48335400 | ||
Tic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndrome | Q48444213 | ||
A functional magnetic resonance imaging study of tic suppression in Tourette syndrome | Q48485554 | ||
Psychiatric disorders and behavioral problems in children and adolescents with Tourette syndrome. | Q51889640 | ||
A controlled family study of attention-deficit/hyperactivity disorder and Tourette's disorder. | Q51929857 | ||
Obsessive-compulsive symptom dimensions in affected sibling pairs diagnosed with Gilles de la Tourette syndrome. | Q52025869 | ||
Tourette's syndrome | Q56093354 | ||
A twin study of Tourette syndrome | Q69840888 | ||
The functional neuroanatomy of Tourette's syndrome: an FDG-PET Study. II: Relationships between regional cerebral metabolism and associated behavioral and cognitive features of the illness | Q70992058 | ||
Bilineal transmission in Tourette's syndrome families | Q72884108 | ||
Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial | Q73621800 | ||
Anxiety disorders and tic severity in juveniles with Tourette's disorder | Q73767215 | ||
Obsessive-compulsive disorder and Tourette syndrome: is there a relationship? | Q74161309 | ||
P433 | issue | 2 | |
P921 | main subject | Tourette syndrome | Q191779 |
P304 | page(s) | 119-125 | |
P577 | publication date | 2011-04-01 | |
P1433 | published in | Current Opinion in Neurology | Q15716647 |
P1476 | title | Recent advances in Tourette syndrome | |
P478 | volume | 24 |
Q30395243 | Animal models of tic disorders: a translational perspective |
Q34296626 | Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials |
Q43044372 | Case report on Tourette syndrome treated successfully with aripiprazole |
Q37154566 | Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette's disorder. |
Q50616608 | Deep TMS add-on treatment for intractable Tourette syndrome: A feasibility study. |
Q36328102 | Dysfunctions of the basal ganglia-cerebellar-thalamo-cortical system produce motor tics in Tourette syndrome |
Q26768144 | Functional Evaluations of Genes Disrupted in Patients with Tourette's Disorder |
Q27008846 | Genetic susceptibility and neurotransmitters in Tourette syndrome |
Q41271494 | Histamine H3R receptor activation in the dorsal striatum triggers stereotypies in a mouse model of tic disorders |
Q41635706 | Histamine regulation of microglia: Gene-environment interaction in the regulation of central nervous system inflammation |
Q47136632 | Histidine Decarboxylase Knockout Mice as a Model of the Pathophysiology of Tourette Syndrome and Related Conditions |
Q30421144 | Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice |
Q89991801 | Impaired automatic but intact volitional inhibition in primary tic disorders |
Q36104865 | Investigation of a Possible Role for the Histidine Decarboxylase Gene in Tourette Syndrome in the Chinese Han Population: A Family-Based Study |
Q36614225 | Involvement of tryptophan hydroxylase 2 gene polymorphisms in susceptibility to tic disorder in Chinese Han population |
Q50939082 | LY294002, a PI3K inhibitor, attenuates Tourette syndrome in rats. |
Q48159655 | Lipopolysaccharide aggravated DOI-induced Tourette syndrome: elaboration for recurrence of Tourette syndrome |
Q36589721 | Pathogenetic model for Tourette syndrome delineates overlap with related neurodevelopmental disorders including Autism. |
Q50090828 | Phenotype Development in Adolescents With Tourette Syndrome: A Large Clinical Longitudinal Study |
Q34714544 | Prenatal and Perinatal Morbidity in Children with Tic Disorders: A Mainstream School-based Population Study in Central Spain |
Q28972411 | Prenatal risk factors for Tourette Syndrome: a systematic review |
Q92060742 | Putamen gray matter volumes in neuropsychiatric and neurodegenerative disorders |
Q26863507 | Response inhibition and interference control in obsessive-compulsive spectrum disorders |
Q35619027 | Sensory sensitivity to external stimuli in Tourette syndrome patients |
Q39333288 | Slitrk gene duplication and expression in the developing zebrafish nervous system |
Q41268522 | Streptococcal infection and immune response in children with Tourette's syndrome |
Q83629652 | The genetics of Tourette syndrome |
Q35208541 | The role of atypical antipsychotics for treatment of Tourette's syndrome: an overview |
Q37536359 | Tourette syndrome and chronic tic disorder are associated with lower socio-economic status: findings from the Avon Longitudinal Study of Parents and Children cohort |
Q38274605 | Tourette syndrome and procedures related to dental treatment: a systematic review |
Search more.